Figs Announces Q3 Earnings Per Share of 5 Cents, Exceeding Consensus Estimate of 2 Cents
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 06 2025
0mins
Should l Buy FIGS?
Q3 Revenue Performance: FIGS reported a Q3 revenue of $151.7 million, surpassing the consensus estimate of $142.46 million.
CEO's Statement: Trina Spear, CEO and Co-Founder, highlighted that the results exceeded internal expectations and marked the strongest revenue growth in two years.
Business Momentum: The company attributes its success to a strong product assortment and impactful brand moments, which have driven momentum in scrubwear and the U.S. business.
Long-term Outlook: FIGS believes that their strategic actions will enhance the fundamental drivers of their healthy business in the long run, reinforcing their position as leaders in the market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FIGS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FIGS
Wall Street analysts forecast FIGS stock price to fall
5 Analyst Rating
2 Buy
2 Hold
1 Sell
Hold
Current: 14.220
Low
7.50
Averages
10.70
High
15.00
Current: 14.220
Low
7.50
Averages
10.70
High
15.00
About FIGS
FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle brand. The Company sells products designed to serve the particular needs of healthcare professionals primarily through its direct-to-consumer (DTC) digital platform, consisting of its Website, mobile app and B2B business (TEAMS). Its offerings include scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. Its non-scrubwear products are designed as an integrated system that complements its scrubwear and are comprised of base layer and outer layer products. Its underscrubs include sports bras, performance leggings, performance tops and super-soft pima cotton tops. Its under underscrubs include several styles of underwear. Its outer layer products include footwear, lab coats, and a variety of vests, jackets, and fleeces. The Company also offers necessities, such as scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
U.S. Stocks Decline Amid Rising Energy Costs and Inflation Fears
- Market Decline: The S&P 500 Index fell by 0.88% and the Nasdaq 100 Index dropped by 1.22%, both reaching 3.75-month lows, indicating market concerns over rising energy costs potentially impacting economic growth and inflation.
- Rising Bond Yields: The 10-year Treasury note yield rose to 4.38%, a 7.5-month high, reflecting market fears that surging energy prices from the Iran conflict will boost inflation and may force the Fed to tighten monetary policy.
- Escalating International Tensions: The Iran war has entered its 21st day with attacks on neighboring countries, leading Kuwait to shut down refinery units and Saudi Arabia and the UAE intercepting Iranian missiles, worsening market sentiment and increasing investor anxiety.
- Increased Market Volatility: With the quarterly triple witching event, approximately $5.7 trillion in options and derivatives are set to expire, potentially heightening market volatility and further intensifying investor unease.
See More
US Stocks Decline Amid Iran War Concerns
- Market Pressure Intensifies: The S&P 500 index fell by 0.37%, and the Nasdaq 100 dropped to a 3.75-month low as rising bond yields raised inflation concerns, indicating a pessimistic outlook for future economic conditions.
- Surging Energy Prices: The IEA reported that the Iran war is disrupting 7.5 million barrels per day of global oil supply, and the closure of the Strait of Hormuz has obstructed about one-fifth of the world's oil flow, potentially pushing crude prices above the 2008 record high of nearly $150 per barrel.
- Fed Policy Expectations: The market is pricing in only a 10% chance of a 25 basis point rate hike by the Fed at the April meeting, reflecting investor concerns over slowing economic growth, which could influence future monetary policy directions.
- Tech Stocks Decline: The
See More
Key Wall Street Rating Updates on Friday
- Nvidia Rating Reaffirmed: Wolfe maintains Nvidia as an outperform, stating that with the stock priced at just 13x their bull case EPS, it is too cheap to ignore, potentially attracting more investor interest.
- Arm Upgrade: HSBC upgrades Arm from reduce to buy, highlighting its strong positioning in the AI sector, suggesting that its transition to a major AI server CPU player presents a significant undervaluation opportunity for investors.
- Apple App Store Revenue Slowdown: Morgan Stanley reiterates Apple as overweight, noting that App Store revenue growth decelerated to 6% YoY in Q1 2023, falling short of the expected 8%, indicating market caution regarding Apple's future growth prospects.
- Oneok Upgrade: Jefferies upgrades Oneok from hold to buy, citing tangible upside potential in the current market environment, particularly as geopolitical tensions in the Middle East raise crude oil price risks.
See More
Healthcare is Human Act Aims to Address Workforce Shortages
- Legislative Background: The Healthcare is Human Act, sponsored by Representatives Claudia Tenney and Steven Horsford, aims to address workforce shortages and burnout in the healthcare sector by providing a federal tax credit of up to $6,000 per year, thereby enhancing service quality and attracting more professionals to the field.
- Industry Status: According to the federal Health Services and Resources Administration, there are over 8,200 primary care, 7,200 dental, and 6,600 mental health shortage areas nationwide, highlighting the urgency for medical services and the critical need for skilled professionals.
- Policy Impact: This legislation not only offers financial incentives to healthcare professionals working in shortage areas but also aims to reduce turnover by improving pay and working conditions, ensuring that communities receive the medical care they need.
- Corporate Support: FIGS CEO Trina Spear emphasized that this historic bill recognizes the contributions of healthcare professionals through tax credits, demonstrating a commitment to the healthcare sector and further promoting sustainable industry growth.
See More
Healthcare is Human Act Introduced to Support Healthcare Workers
- Legislative Background: The bipartisan Healthcare is Human Act, co-sponsored by Reps. Claudia Tenney and Steven Horsford, aims to provide a federal tax credit of up to $6,000 annually to healthcare professionals, directly addressing low pay and staffing shortages that contribute to burnout and turnover in the healthcare sector.
- Healthcare Shortage Reality: According to the latest report from the federal Health Services and Resources Administration, there are over 8,200 primary care, 7,200 dental, and 6,600 mental health shortage areas in the U.S., highlighting the urgent need for healthcare services, and the implementation of this legislation will help attract more professionals to these critical fields.
- Policy Impact: This act not only provides financial incentives for current healthcare workers but also aims to improve medical services in rural areas and those serving veterans, ensuring these communities receive timely care and ultimately enhancing overall public health outcomes.
- Industry Response: FIGS CEO Trina Spear stated that this legislation is historic, reflecting recognition and support for healthcare professionals, emphasizing the importance of the healthcare industry to society, and hopes to enhance the respect and value of healthcare workers through this initiative.
See More
Wall Street's Affection for FIGS: What Do Price Targets Indicate About a Potential Decline?
Stock Performance: Following a significant recovery, FIGS, Inc. has seen its stock surge nearly 260% over the past year, currently trading above $17, despite a consensus 12-month price target of $12.25, indicating skepticism about its valuation.
Earnings Momentum: The company reported strong earnings growth, with Q3 2025 results exceeding expectations, leading to a stock rally of over 30% and prompting analysts to upgrade their ratings, reflecting confidence in FIGS' future prospects.
Market Challenges: Despite positive earnings, analysts express caution regarding the stock's valuation, noting that it trades at a high price-to-earnings ratio, suggesting that much of the expected growth may already be priced in.
Future Outlook: FIGS anticipates continued revenue growth of 10% to 12% for fiscal 2026, driven by strong demand in the healthcare sector, while also planning to expand into new international markets and maintain its stock buyback program.
See More
U.S. Stocks Decline Amid Rising Energy Costs and Inflation Fears
- Market Decline: The S&P 500 Index fell by 0.88% and the Nasdaq 100 Index dropped by 1.22%, both reaching 3.75-month lows, indicating market concerns over rising energy costs potentially impacting economic growth and inflation.
- Rising Bond Yields: The 10-year Treasury note yield rose to 4.38%, a 7.5-month high, reflecting market fears that surging energy prices from the Iran conflict will boost inflation and may force the Fed to tighten monetary policy.
- Escalating International Tensions: The Iran war has entered its 21st day with attacks on neighboring countries, leading Kuwait to shut down refinery units and Saudi Arabia and the UAE intercepting Iranian missiles, worsening market sentiment and increasing investor anxiety.
- Increased Market Volatility: With the quarterly triple witching event, approximately $5.7 trillion in options and derivatives are set to expire, potentially heightening market volatility and further intensifying investor unease.
See More
US Stocks Decline Amid Iran War Concerns
- Market Pressure Intensifies: The S&P 500 index fell by 0.37%, and the Nasdaq 100 dropped to a 3.75-month low as rising bond yields raised inflation concerns, indicating a pessimistic outlook for future economic conditions.
- Surging Energy Prices: The IEA reported that the Iran war is disrupting 7.5 million barrels per day of global oil supply, and the closure of the Strait of Hormuz has obstructed about one-fifth of the world's oil flow, potentially pushing crude prices above the 2008 record high of nearly $150 per barrel.
- Fed Policy Expectations: The market is pricing in only a 10% chance of a 25 basis point rate hike by the Fed at the April meeting, reflecting investor concerns over slowing economic growth, which could influence future monetary policy directions.
- Tech Stocks Decline: The
See More
Key Wall Street Rating Updates on Friday
- Nvidia Rating Reaffirmed: Wolfe maintains Nvidia as an outperform, stating that with the stock priced at just 13x their bull case EPS, it is too cheap to ignore, potentially attracting more investor interest.
- Arm Upgrade: HSBC upgrades Arm from reduce to buy, highlighting its strong positioning in the AI sector, suggesting that its transition to a major AI server CPU player presents a significant undervaluation opportunity for investors.
- Apple App Store Revenue Slowdown: Morgan Stanley reiterates Apple as overweight, noting that App Store revenue growth decelerated to 6% YoY in Q1 2023, falling short of the expected 8%, indicating market caution regarding Apple's future growth prospects.
- Oneok Upgrade: Jefferies upgrades Oneok from hold to buy, citing tangible upside potential in the current market environment, particularly as geopolitical tensions in the Middle East raise crude oil price risks.
See More
Healthcare is Human Act Aims to Address Workforce Shortages
- Legislative Background: The Healthcare is Human Act, sponsored by Representatives Claudia Tenney and Steven Horsford, aims to address workforce shortages and burnout in the healthcare sector by providing a federal tax credit of up to $6,000 per year, thereby enhancing service quality and attracting more professionals to the field.
- Industry Status: According to the federal Health Services and Resources Administration, there are over 8,200 primary care, 7,200 dental, and 6,600 mental health shortage areas nationwide, highlighting the urgency for medical services and the critical need for skilled professionals.
- Policy Impact: This legislation not only offers financial incentives to healthcare professionals working in shortage areas but also aims to reduce turnover by improving pay and working conditions, ensuring that communities receive the medical care they need.
- Corporate Support: FIGS CEO Trina Spear emphasized that this historic bill recognizes the contributions of healthcare professionals through tax credits, demonstrating a commitment to the healthcare sector and further promoting sustainable industry growth.
See More
Healthcare is Human Act Introduced to Support Healthcare Workers
- Legislative Background: The bipartisan Healthcare is Human Act, co-sponsored by Reps. Claudia Tenney and Steven Horsford, aims to provide a federal tax credit of up to $6,000 annually to healthcare professionals, directly addressing low pay and staffing shortages that contribute to burnout and turnover in the healthcare sector.
- Healthcare Shortage Reality: According to the latest report from the federal Health Services and Resources Administration, there are over 8,200 primary care, 7,200 dental, and 6,600 mental health shortage areas in the U.S., highlighting the urgent need for healthcare services, and the implementation of this legislation will help attract more professionals to these critical fields.
- Policy Impact: This act not only provides financial incentives for current healthcare workers but also aims to improve medical services in rural areas and those serving veterans, ensuring these communities receive timely care and ultimately enhancing overall public health outcomes.
- Industry Response: FIGS CEO Trina Spear stated that this legislation is historic, reflecting recognition and support for healthcare professionals, emphasizing the importance of the healthcare industry to society, and hopes to enhance the respect and value of healthcare workers through this initiative.
See More
Wall Street's Affection for FIGS: What Do Price Targets Indicate About a Potential Decline?
Stock Performance: Following a significant recovery, FIGS, Inc. has seen its stock surge nearly 260% over the past year, currently trading above $17, despite a consensus 12-month price target of $12.25, indicating skepticism about its valuation.
Earnings Momentum: The company reported strong earnings growth, with Q3 2025 results exceeding expectations, leading to a stock rally of over 30% and prompting analysts to upgrade their ratings, reflecting confidence in FIGS' future prospects.
Market Challenges: Despite positive earnings, analysts express caution regarding the stock's valuation, noting that it trades at a high price-to-earnings ratio, suggesting that much of the expected growth may already be priced in.
Future Outlook: FIGS anticipates continued revenue growth of 10% to 12% for fiscal 2026, driven by strong demand in the healthcare sector, while also planning to expand into new international markets and maintain its stock buyback program.
See More
